4-(3-Hydroxypropyl)morpholine - CAS 4441-30-9
Catalog: |
BB025603 |
Product Name: |
4-(3-Hydroxypropyl)morpholine |
CAS: |
4441-30-9 |
Synonyms: |
3-morpholin-4-ylpropan-1-ol |
IUPAC Name: | 3-morpholin-4-ylpropan-1-ol |
Description: | 4-(3-Hydroxypropyl)morpholine (CAS# 4441-30-9) is a useful research chemical. |
Molecular Weight: | 145.20 |
Molecular Formula: | C7H15NO2 |
Canonical SMILES: | C1COCCN1CCCO |
InChI: | InChI=1S/C7H15NO2/c9-5-1-2-8-3-6-10-7-4-8/h9H,1-7H2 |
InChI Key: | VZKSLWJLGAGPIU-UHFFFAOYSA-N |
Boiling Point: | 240-241 °C |
Purity: | 98 % |
Density: | 1.049 g/cm3 |
Appearance: | Pale yellow to yello clear liquid |
MDL: | MFCD01713533 |
LogP: | -0.36110 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112574177-A | Pyrimidine derivatives and application thereof in preparing antitumor drugs | 20201221 |
KR-20200116443-A | A resist stripper composition for preventing unevenness | 20200929 |
WO-2021202694-A1 | Phenolic acid lipid based cationic lipids | 20200401 |
KR-20210093155-A | Novel compound, preparation method thereof, and use thereof | 20200117 |
WO-2021145729-A1 | Novel compound, preparation method thereof, and use thereof | 20200117 |
PMID | Publication Date | Title | Journal |
19245689 | 20090226 | Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis | BMC cancer |
16204931 | 20051001 | A specific and sensitive assay for gefitinib using the enzyme-linked immunosorbent assay in human serum | Biological & pharmaceutical bulletin |
11689083 | 20011108 | Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity | Journal of medicinal chemistry |
11262092 | 20010301 | Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles | Journal of medicinal chemistry |
Complexity: | 81.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.110278721 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.110278721 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 32.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.4 |
-
Catalog: BB026817
N,N'-Dicyclohexyl-4-morpholinecarboxamidine
Detail
-
Catalog: BB003037
(2S,3R)-N-Boc-6-oxo-2,3-diphenylmorpholine
Detail
-
Catalog: BB018272
2-Phenylmorpholine Hydrochloride
Detail
-
Catalog: BB028290
4-Morpholinopiperidine
Detail
-
Catalog: BB007746
2,4-Dimorpholinonitrobenzene
Detail
-
Catalog: BB022035
Morpholine-2,2,3,3,5,5,6,6-D8
Detail
-
Catalog: BB002238
N-Ethyl-2-morpholin-4-ylethanamine
Detail
-
Catalog: BB001891
2,5-Dimethylmorpholine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Morpholines/Thiomorpholines
Customers Also Viewed
-
[891016-02-7]
ML-SI3
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[133407-82-6]
MG-132
-
[1808-26-0]
Ethyl arachidonate
-
[138169-43-4]
MTS Reagent
-
[84030-20-6]
MTBD
INDUSTRY LEADERS TRUST OUR PRODUCTS